C COMPREHENSIVE CELL SOLUTIONS
DEAD

Serial Number

87710794

Owner

NEW YORK BLOOD CENTER, INC.

Attorney

Cynthia Johnson Walden

First Use Date

Nov 14, 2016

Filing Date

Dec 6, 2017

Add to watchlist:

No watchlists yet
View on USPTO

C COMPREHENSIVE CELL SOLUTIONS Trademark

Serial Number: 87710794 • Registration: 5573698

C COMPREHENSIVE CELL SOLUTIONS is a trademark filed by NEW YORK BLOOD CENTER, INC. on December 6, 2017. The trademark is classified under Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NEW YORK BLOOD CENTER, INC. (46 trademarks)

NEW YORK, NY 10021

Entity Type: 99

Trademark Details

Filing Date

December 6, 2017

Registration Date

October 2, 2018

First Use Anywhere

November 14, 2016

First Use in Commerce

November 14, 2016

Published for Opposition

July 17, 2018

Cancellation Date

April 18, 2025

Goods & Services

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, cryopreservation of human cells

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, storage of blood and stem cells

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, providing independent review of clinical trials for business purposes

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, tissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow

Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, medical laboratory, pharmaceutical research services and pharmaceutical clinical trials for others

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 18, 2025 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 6, 2024 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 2, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 2, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 17, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 20, 2018 GPRN
PRIORITY ACTION E-MAILED
Mar 20, 2018 GPRA
PRIORITY ACTION WRITTEN
Mar 20, 2018 CPRA
ASSIGNED TO EXAMINER
Mar 13, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 19, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2017 NWOS
NEW APPLICATION ENTERED
Dec 13, 2017 NWAP